Community Analytics is excited to be working alongside our research partner on this very important engagement:  Improving the lives of patients suffering with Multiple Sclerosis by understanding patient advocacy support groups and improving the resources made available to them.

Background:
Multiple Sclerosis (MS) is a debilitating autoimmune disease that affects millions of people each year in the US and around the world. While there is no cure for MS at this time, Pharmaceutical companies have developed effective therapies that help MS patients control symptoms and slow progression of the disease. A new therapy, expected to be the best available to date, has recently cleared clinical trials and will be entering the market soon.